CC
Income statement / Annual
Last year (2025), Chemours Company's total revenue was $5.81 B,
an increase of 0.45% from the previous year.
In 2025, Chemours Company's net income was -$386.00 M.
See Chemours Company,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$5.81 B |
$5.78 B |
$6.08 B |
$6.83 B |
$6.35 B |
$4.97 B |
$5.53 B |
$6.64 B |
$6.18 B |
$5.40 B |
| Cost of Revenue |
$4.91 B
|
$4.63 B
|
$4.77 B
|
$5.22 B
|
$4.96 B
|
$3.90 B
|
$4.46 B
|
$4.67 B
|
$4.43 B
|
$4.29 B
|
| Gross Profit |
$902.00 M
|
$1.15 B
|
$1.31 B
|
$1.62 B
|
$1.38 B
|
$1.07 B
|
$1.06 B
|
$1.97 B
|
$1.75 B
|
$1.11 B
|
| Gross Profit Ratio |
0.16
|
0.2
|
0.21
|
0.24
|
0.22
|
0.21
|
0.19
|
0.3
|
0.28
|
0.21
|
| Research and Development Expenses |
$108.00 M
|
$109.00 M
|
$108.00 M
|
$118.00 M
|
$107.00 M
|
$93.00 M
|
$80.00 M
|
$82.00 M
|
$80.00 M
|
$80.00 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$799.00 M
|
$585.00 M
|
$1.29 B
|
$710.00 M
|
$592.00 M
|
$0.00
|
$0.00
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
| Other Expenses |
$0.00
|
$14.00 M
|
$31.00 M
|
$2.00 M
|
$8.00 M
|
$526.00 M
|
$536.00 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$907.00 M
|
$708.00 M
|
$1.43 B
|
$830.00 M
|
$707.00 M
|
$619.00 M
|
$616.00 M
|
$739.00 M
|
$682.00 M
|
$1.01 B
|
| Cost And Expenses |
$5.81 B
|
$5.34 B
|
$6.20 B
|
$6.05 B
|
$5.67 B
|
$4.52 B
|
$5.08 B
|
$5.41 B
|
$5.11 B
|
$5.30 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$269.00 M
|
$264.00 M
|
$208.00 M
|
$163.00 M
|
$185.00 M
|
$210.00 M
|
$208.00 M
|
$195.00 M
|
$215.00 M
|
$219.00 M
|
| Depreciation & Amortization |
$340.00 M
|
$301.00 M
|
$307.00 M
|
$291.00 M
|
$317.00 M
|
$320.00 M
|
$268.00 M
|
$284.00 M
|
$273.00 M
|
$284.00 M
|
| EBITDA |
$332.00 M |
$692.00 M |
$197.00 M |
$1.20 B |
$1.18 B |
$767.00 M |
$715.00 M |
$1.54 B |
$1.35 B |
$715.00 M |
| EBITDA Ratio |
0.06
|
0.12
|
0.03
|
0.17
|
0.19
|
0.15
|
0.13
|
0.23
|
0.22
|
0.13
|
| Operating Income Ratio |
-0
|
0.08
|
-0.02
|
0.12
|
0.11
|
0.09
|
0.08
|
0.19
|
0.17
|
0.02
|
| Total Other Income/Expenses Net |
-$272.00 M
|
-$316.00 M
|
-$195.00 M
|
-$45.00 M
|
$2.00 M
|
-$269.00 M
|
-$427.00 M
|
-$77.00 M
|
-$160.00 M
|
-$107.00 M
|
| Income Before Tax |
-$277.00 M
|
$127.00 M
|
-$318.00 M
|
$741.00 M
|
$676.00 M
|
$179.00 M
|
$20.00 M
|
$1.16 B
|
$912.00 M
|
-$11.00 M
|
| Income Before Tax Ratio |
-0.05
|
0.02
|
-0.05
|
0.11
|
0.11
|
0.04
|
0
|
0.17
|
0.15
|
-0
|
| Income Tax Expense |
$109.00 M
|
$41.00 M
|
-$81.00 M
|
$163.00 M
|
$68.00 M
|
-$40.00 M
|
$72.00 M
|
$159.00 M
|
$165.00 M
|
-$18.00 M
|
| Net Income |
-$386.00 M
|
$86.00 M
|
-$238.00 M
|
$578.00 M
|
$608.00 M
|
$219.00 M
|
-$52.00 M
|
$995.00 M
|
$746.00 M
|
$7.00 M
|
| Net Income Ratio |
-0.07
|
0.01
|
-0.04
|
0.08
|
0.1
|
0.04
|
-0.01
|
0.15
|
0.12
|
0
|
| EPS |
-2.57 |
0.58 |
-1.6 |
3.72 |
3.69 |
1.33 |
-0.32 |
5.62 |
4.04 |
0.04 |
| EPS Diluted |
-2.56 |
0.57 |
-1.6 |
3.65 |
3.6 |
1.32 |
-0.32 |
5.45 |
3.91 |
0.04 |
| Weighted Average Shares Out |
$150.35 M
|
$149.49 M
|
$148.91 M
|
$155.36 M
|
$164.94 M
|
$164.68 M
|
$164.82 M
|
$176.97 M
|
$184.84 M
|
$181.62 M
|
| Weighted Average Shares Out Diluted |
$150.55 M
|
$150.01 M
|
$148.91 M
|
$158.30 M
|
$168.70 M
|
$166.35 M
|
$164.82 M
|
$182.57 M
|
$190.98 M
|
$183.42 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
